Published in Eur J Pharmacol on August 27, 1985
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A (2006) 1.95
Pyrazolone derivatives. Drugs (1986) 1.72
Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A (2004) 1.29
Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization. Proc Natl Acad Sci U S A (2003) 1.02
The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs (1993) 0.96
Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway. Mol Pain (2012) 0.96
Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues. Br J Pharmacol (2003) 0.93
Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195. Br J Pharmacol (1992) 0.88
NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain. Pharmacol Res Perspect (2015) 0.85
Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite cells. Proc Natl Acad Sci U S A (2014) 0.81
Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
The nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats. Neuropharmacology (2013) 0.80
Dual effects of Rho-kinase inhibitors on a rat model of inflammatory pain. Pain Res Manag (2014) 0.79
Antinociceptive activity of the ethanolic extract, fractions, and aggregatin D isolated from Sinningia aggregata tubers. PLoS One (2015) 0.79
The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives. Br J Pharmacol (2015) 0.78
The antipyretic effect of dipyrone is unrelated to inhibition of PGE(2) synthesis in the hypothalamus. Br J Pharmacol (2011) 0.78
Long-term Morphine-treated Rats are more Sensitive to Antinociceptive Effect of Diclofenac than the Morphine-naive rats. Iran J Pharm Res (2013) 0.78
Synergism between COX-3 inhibitors in two animal models of pain. Inflammopharmacology (2010) 0.76
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance. Br J Pharmacol (1995) 0.75
Dipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2 -dependent and -independent fever while 4-AA only blocks PGE2 -dependent fever. Br J Pharmacol (2014) 0.75
Prostaglandins: their disappearance from and release into the circulation. Nature (1967) 8.66
Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol (1971) 5.62
Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol (1972) 4.91
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature (1973) 3.20
Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature (1988) 2.72
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A (2005) 2.53
The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother (1967) 2.44
Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol (1978) 2.18
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol (2000) 2.16
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol (1973) 2.07
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry (1970) 1.86
Proceedings: Prostaglandin generation maintains the smooth muscle tone of the rabbit isolated jejunum. Br J Pharmacol (1972) 1.80
The detection and estimation of bradykinin in the circulating blood. Br J Pharmacol Chemother (1967) 1.80
The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins (1978) 1.74
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol (1991) 1.71
Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res (1988) 1.66
II - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins (1979) 1.63
An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res (2004) 1.56
IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology (1991) 1.54
A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol (1987) 1.53
I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins (1979) 1.52
Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen. Br J Pharmacol (1973) 1.47
Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions (1985) 1.45
Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol (1993) 1.44
An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res (2004) 1.39
The effects of antiinflammatory drugs on the production of prostaglandins in vivo. Adv Prostaglandin Thromboxane Res (1976) 1.36
Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur J Pharmacol (1975) 1.34
Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol (1990) 1.32
Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis (2000) 1.30
The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience (2001) 1.30
A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances. Eur J Pharmacol (1976) 1.29
Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation. Br J Pharmacol (1976) 1.29
Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A (2008) 1.28
Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme. Nature (1970) 1.27
Half-lives of peptides and amines in the circulation. Nature (1967) 1.27
The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol (1991) 1.26
An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia. Cardiovasc Res (1976) 1.24
Rat knee-joint carrageenin incapacitation test: an objective screen for central and peripheral analgesics. Pain (1992) 1.22
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia. Br J Pharmacol (1999) 1.22
Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances. Eur J Pharmacol (1988) 1.20
Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines. Br J Pharmacol (1971) 1.20
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol (1995) 1.17
Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis. Br J Pharmacol (1973) 1.16
Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol (2000) 1.14
Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions (1988) 1.13
Proceedings: Potentiation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint. Br J Pharmacol (1974) 1.12
The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur J Pharmacol (1986) 1.12
Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Br J Pharmacol (2001) 1.12
Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol (1992) 1.11
Bradykinin and functional vasodilatation in the salivary gland. Br J Pharmacol (1976) 1.10
Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol (2006) 1.10
Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol (1994) 1.06
Analgesic effect of thalidomide on inflammatory pain. Eur J Pharmacol (2000) 1.06
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol (1999) 1.06
The continuous bioassay of the release and disappearance of histamine in the circulation. Br J Pharmacol (1973) 1.05
Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors. Braz J Med Biol Res (1981) 1.04
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol (1999) 1.02
Blockade of hyperalgesia and neurogenic oedema by topical application of nitroglycerin. Eur J Pharmacol (1992) 1.02
Are platelets important in inflammation? Agents Actions (1975) 1.01
A new method for measuring variations of rat paw volume. J Pharm Pharmacol (1979) 1.00
Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol (2002) 0.99
The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils. Immunology (1996) 0.99
Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists. Br J Clin Pharmacol (1980) 0.98
Antinociceptive models displaying peripheral opioid activity. Int J Tissue React (1985) 0.98
Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol (2008) 0.98
History of the development of inhibitors of angiotensin I conversion. Drugs (1985) 0.98
Does the pro-inflammatory factor in lymphocytes (LpIF) explain the role of these cells in acute inflammation? Agents Actions (1976) 0.97
Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol (1997) 0.97
Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur J Pharmacol (1993) 0.96
Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia (1965) 0.96
Bioassay of prostaglandins and biologically active substances derived from arachidonic acid. Adv Prostaglandin Thromboxane Res (1978) 0.96
Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol (2006) 0.96
The analgesic effect of quaternary analogues of morphine and nalorphine. Braz J Med Biol Res (1982) 0.95
The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol (1992) 0.95
III - Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists. Prostaglandins (1979) 0.95
Recombinant gamma interferon causes neutrophil migration mediated by the release of a macrophage neutrophil chemotactic factor. Int J Exp Pathol (1990) 0.94
Restoration by levamisole of endotoxin-inhibited neutrophil migration, oedema and increased vascular permeability induced by carrageenin. Eur J Pharmacol (1986) 0.93
Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc Natl Acad Sci U S A (2007) 0.93
Proceedings: the concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin. Br J Pharmacol (1974) 0.93
Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm Res (1996) 0.93
Release of kinins from fresh plasma under varying experimental conditions. Biochem Pharmacol (1967) 0.92
A novel technique to perform direct intraganglionar injections in rats. J Neurosci Methods (2006) 0.92
IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. Br J Pharmacol (2013) 0.91
Biological characterization of purified macrophage-derived neutrophil chemotactic factor. Mediators Inflamm (1995) 0.91
Nitric oxide mediates the microbicidal activity of eosinophils. Mem Inst Oswaldo Cruz (1997) 0.90
Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion. Br J Pharmacol (1994) 0.90
Is methylnalorphinium the prototype of an ideal peripheral analgesic? Eur J Pharmacol (1984) 0.90